Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:41:36.892Z.
Calculation as of: 2026-10-06T13:41:36.892Z.
Quote observation: 2026-10-06T13:40:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d42caa3e816b0495fa2340ecfe28e9cd39b3fd8bb52e96b9f838481ccca068c7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
C4 Therapeutics, Inc.
Market Cap
$329.49M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$339.93M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.85M
Free Cash Flow Yield
47.18%
TTM Avg
52.29%
3Y Avg
21.98%
5Y Avg
21.35%
Market Cap
$311.25M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.63M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$305.38M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $329.49M | N/A | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $334.26M | N/A | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $339.93M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $318.27M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $348.85M | 47.18% | 52.29% | 21.98% | 21.35% |
| Benitec Biopharma Inc. (BNTC)vs › | $311.25M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $348.63M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $350.42M | N/A | 0.01% | 0.01% | 0.01% |
| Standard BioTools Inc. (LAB)vs › | $305.38M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $359.16M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
